Financials

  • Market Capitalization 6.88 M
  • Employee 5
  • Founded 2022
  • CEO N/A
  • Website www.cadrenal.com
  • Headquarter Delaware, United States
  • FIGI BBG019STRT20
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.02
Price to sales ratio
Dividends per share
16.5
Dividend yield %
243.36

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4901
ERNA
Ernexa Therapeutics Inc. - Common Stock
6.06 USD+9.39%-5.75%-7.62%+1633.91%7.07 M USD
4904
CNSP
CNS Pharmaceuticals, Inc. - Common Stock
4.86 USD-4.52%-6.72%+1.46%+458.62%7.10 M USD
4913
ACXP
Acurx Pharmaceuticals, Inc. - Common Stock
1.64 USD+3.80%+13.10%+1.23%-14.58%7.05 M USD
4917
XTLB
XTL Biopharmaceuticals Ltd - American Depositary Shares
2.90 USD+0.69%-2.68%+25.54%+222.94%6.86 M USD

Frequently asked questions about Cadrenal Therapeutics, Inc. - Common Stock

What is the Cadrenal Therapeutics, Inc. - Common Stock stock price today?

The current price of Cadrenal Therapeutics, Inc. - Common Stock (CVKD) is 2.4. Over the past 24 hours, the stock has changed by -0.83%. Follow the CVKD chart for real-time price dynamics.

What is the stock ticker of Cadrenal Therapeutics, Inc. - Common Stock?

Cadrenal Therapeutics, Inc. - Common Stock trades under the ticker CVKD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Cadrenal Therapeutics, Inc. - Common Stock stock going up?

CVKD has changed by -24.05% over the last week, -36.84% over the last month, and -56.52% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Cadrenal Therapeutics, Inc. - Common Stock net income for the last quarter?

Cadrenal Therapeutics, Inc. - Common Stock reported net income of -2.5 M for the last quarter. The previous quarter showed -3.04 M, which means net income changed by +17.85%.

How many employees does Cadrenal Therapeutics, Inc. - Common Stock have?

As of the latest available data, Cadrenal Therapeutics, Inc. - Common Stock has 5 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Cadrenal Therapeutics, Inc. - Common Stock stock?

You can buy Cadrenal Therapeutics, Inc. - Common Stock (CVKD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Cadrenal Therapeutics, Inc. - Common Stock stock?

Investing in Cadrenal Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CVKD chart and related analysis on metatrader.com as part of your research.

News